Name: the application of 1% methylene blue dye as a single technique in breast cancer sentinel node biopsy
Uploaded: 2019-06-01T12:30:00
Description: Watch this Scientific Journal Video about The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy at JoVE.com

The authors have nothing to disclose.

All procedures including human subjects have been approved by Dharmais Cancer Hospital Ethics Committee with certificate number of 040/KEPK/VII/2017. All patients signed the consent forms and expressed agreement to participate in this study.
NOTE: The inclusion criteria are patients with diagnosis of early breast cancer, with tumor stage T1-T2 without palpable and ultrasonography lymph nodes enlargement (cNo). The exclusion criteria are locally advanced breast cancer, received neo adjuvant che...

<ol>
	<li>Giuliano, A. E., Han, S. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Local+and+regional+control+in+breast+cancer:+role+of+sentinel+node+biopsy.">Local and regional control in breast cancer: role of sentinel node biopsy.</a> Advances in Surgery. 45 (1), 101-116 (2011).</li><li>D'Angelo-Donovan, D. D., Dickson-Witmer, D., Petrelli, N. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Sentinel+lymph+node+biopsy+in+breast+cancer:+a+history+and+current+clinical+recommendations.">Sentinel lymph node biopsy in breast cancer: a history and current clinical recommendations.</a> Surgical Oncology. 21 (3), 196-200 (2012).</li><li>McLaughlin, S. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Prevalence+of+lymphedema+in+women+with+breast+cancer+5+years+after+sentinel+lymph+node+biopsy+or+axillary+dissection:+objective+measurements.">Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.</a> Journal of Clinical Oncology. 26 (32), 5213-5219 (2008).</li><li>Erickson, V. S., Pearson, M. L., Ganz, P. A., Adams, J., Kahn, K. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Arm+edema+in+breast+cancer+patients.">Arm edema in breast cancer patients.</a> Journal of the National Cancer Institute. 93 (2), 96-111 (2001).</li><li>Veronesi, U., Stafyla, V., Luiniand, A., Veronesi, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Breast+cancer:+from+&amp;#34;maximum+tolerable&amp;#34;+to+&amp;#34;minimum+effective&amp;#34;+treatment.">Breast cancer: from &amp;#34;maximum tolerable&amp;#34; to &amp;#34;minimum effective&amp;#34; treatment.</a> Frontiers of Oncology. 2, 1-5 (2012).</li><li>Kim, T., Giuliano, A. E., Lyman, G. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Lymphatic+mapping+and+sentinel+lymph+node+biopsy+in+early-stage+breast+carcinoma:+a+meta-analysis.">Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a meta-analysis.</a> Cancer. 106 (1), 4-16 (2006).</li><li>Wong, J. H., Cagle, L. A., Morton, D. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Lymphatic+drainage+of+skin+to+a+sentinel+lymph+node+in+a+feline+model.">Lymphatic drainage of skin to a sentinel lymph node in a feline model.</a> Annals of Surgery. 214 (5), 637 (1991).</li><li>Simmons, R. M., Smith, S. M. R., Osborne, M. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Methylene+blue+dye+as+an+alternative+to+isosulfan+blue+dye+for+sentinel+lymph+node+localization.">Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization.</a> The Breast Journal. 7 (3), 181-183 (2001).</li><li>Nour, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Efficacy+of+methylene+blue+dye+in+localization+of+sentinel+lymph+node+in+breast+cancer+patients.">Efficacy of methylene blue dye in localization of sentinel lymph node in breast cancer patients.</a> Breast Journal. 10 (5), 388-391 (2004).</li><li>Varghese, P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Methylene+blue+dye+versus+combined+dye-radioactive+tracer+technique+for+sentinel+lymph+node+localisation+in+early+breast+cancer.">Methylene blue dye versus combined dye-radioactive tracer technique for sentinel lymph node localisation in early breast cancer.</a> European Journal of Surgical Oncology. 33 (2), 147-152 (2007).</li><li>Bakhtiar, N., Jaleel, F., Moosa, F. A., Qureshi, N. A., Jawaid, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Sentinel+lymph+node+identification+by+blue+dye+in+patients+with+breast+carcinoma.">Sentinel lymph node identification by blue dye in patients with breast carcinoma.</a> Pakistan Journal of Medical Sciences. 32 (2), 448 (2016).</li><li>Thevarajah, S., Huston, T. L., Simmons, R. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+comparison+of+the+adverse+reactions+associated+with+isosulfan+blue+versus+methylene+blue+dye+in+sentinel+lymph+node+biopsy+for+breast+cancer.">A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.</a> American Journal of Surgical. 189 (2), 236-239 (2005).</li><li>Brahma, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+predictive+value+of+methylene+blue+dye+as+a+single+technique+in+breast+cancer+sentinel+node+biopsy:+a+study+from+Dharmais+Cancer+Hospital.">The predictive value of methylene blue dye as a single technique in breast cancer sentinel node biopsy: a study from Dharmais Cancer Hospital.</a> World journal of Surgical Oncology. 15 (1), 41 (2017).</li><li>Lyman, G. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Sentinel+lymph+node+biopsy+for+patients+with+early-stage+breast+cancer:+American+society+of+clinical+oncology+clinical+practice+guideline+update.">Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update.</a> Journal of Clinical Oncology. 32 (13), 1365-1383 (2014).</li><li>Mamounas, E. P., Kuehn, T., Rutgers, E. J., von Minckwitz, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Current+approach+of+the+axilla+in+patients+with+early-stage+breast+cancer.">Current approach of the axilla in patients with early-stage breast cancer.</a> Lancet. , (2014).</li><li>Peek, M. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Is+blue+dye+still+required+during+sentinel+lymph+node+biopsy+for+breast+cancer?.">Is blue dye still required during sentinel lymph node biopsy for breast cancer?.</a> Ecancermedicalscience. , (2016).</li><li>Lyman, G. H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=American+Society+of+Clinical+Oncology+Guideline+Recommendations+for+Sentinel+Lymph+Node+Biopsy+in+Early-Stage+Breast+Cancer.">American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer.</a> Journal of Clinical Oncology. 23 (30), 7703-7720 (2005).</li><li>Masannat, Y., Shenoy, H., Speirs, V., Hanby, A., Horgan, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Properties+and+characteristics+of+the+dyes+injected+to+assist+axillary+sentinel+node+localization+in+breast+surgery.">Properties and characteristics of the dyes injected to assist axillary sentinel node localization in breast surgery.</a> EJSO. 32 (4), 381-384 (2006).</li><li>Brahma, B., Haryono, S. J., Ramadhan, ., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Methylene+blue+dye+as+a+single+agent+in+breast+cancer+sentinel+lymph+node+biopsy:+initial+study+of+cancer+centre+hospital.">Methylene blue dye as a single agent in breast cancer sentinel lymph node biopsy: initial study of cancer centre hospital.</a> 19th Asian Congress of Surgery &amp; SingHealth Surgical Congress. , (2013).</li><li>Borgstein, P. J., Meijer, S., Pijpers, R. J., van Diest, P. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Functional+Lymphatic+Anatomy+for+Sentinel+Node+Biopsy+in+Breast+Cancer+Echoes+from+the+Past+and+the+Periareolar+Blue+Method.">Functional Lymphatic Anatomy for Sentinel Node Biopsy in Breast Cancer Echoes from the Past and the Periareolar Blue Method.</a> Annals of Surgery. 232 (1), 81 (2000).</li><li>Tuttle, T. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Subareolar+Injection+of+99mTc+Facilitates+Sentinel+Lymph+Node+Identification.">Subareolar Injection of 99mTc Facilitates Sentinel Lymph Node Identification.</a> Annals of Surgical Oncology. 9 (1), 77-81 (2002).</li><li>Suami, H., Pan, W. R., Taylor, G. I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Historical+Review+of+Breast+Lymphatic+Studies.">Historical Review of Breast Lymphatic Studies.</a> Clinical Anatomy. 22 (5), 531-536 (2009).</li><li>Sadeghi, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Axillary+concordance+between+superficial+and+deep+sentinel+node+mapping+material+injections+in+breast+cancer+patients:+systematic+review+and+meta-analysis+of+the+literature.">Axillary concordance between superficial and deep sentinel node mapping material injections in breast cancer patients: systematic review and meta-analysis of the literature.</a> Breast Cancer Research and Treatment. 144 (2), 213-222 (2014).</li><li>Clough, K. B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=New+anatomical+classification+of+the+axilla+with+implications+for+sentinel+node+biopsy.">New anatomical classification of the axilla with implications for sentinel node biopsy.</a> British Journal of Surgery. 97 (11), 1659-1665 (2010).</li><li>Ueda, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Identification+of+sentinel+lymph+node+location+based+on+body+surface+landmarks+in+early+breast+cancer+patients.">Identification of sentinel lymph node location based on body surface landmarks in early breast cancer patients.</a> Breast Cancer. 16 (3), 219-222 (2009).</li><li>Kang, B., Jun, H., Lee, K., Lee, K., Kim, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Clinical+application+of+sentinel+lymph+node+biopsy+based+on+axillary+anatomy+in+breast+cancer:+A+single+institution+experience.">Clinical application of sentinel lymph node biopsy based on axillary anatomy in breast cancer: A single institution experience.</a> The Breast. 23 (6), 812-815 (2014).</li><li>Layfield, D. M., Agrawal, A., Roche, H., Cutress, R. I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Intraoperative+assessment+of+sentinel+lymph+nodes+in+breast+cancer.">Intraoperative assessment of sentinel lymph nodes in breast cancer.</a> British Journal of Surgery. 98 (1), 4-17 (2011).</li><li>Weaver, D. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Pathology+evaluation+of+sentinel+lymph+nodes+in+breast+cancer:+protocol+recommendations+and+rationale.">Pathology evaluation of sentinel lymph nodes in breast cancer: protocol recommendations and rationale.</a> Modern Pathology. 23 (S2), S26 (2010).</li><li>Bishop, J. A., Sun, J., Ajkay, N., Sanders, M. A. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Decline+in+Frozen+Section+Diagnosis+for+Axillary+Sentinel+Lymph+Nodes+as+a+Result+of+the+American+College+of+Surgeons+Oncology+Group+Z0011+Trial.">Decline in Frozen Section Diagnosis for Axillary Sentinel Lymph Nodes as a Result of the American College of Surgeons Oncology Group Z0011 Trial.</a> Archives of Pathology and Laboratory Medicine. 140 (8), 830-835 (2015).</li><li>Thevarajah, S., Huston, T. L., Simmons, R. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+comparison+of+the+adverse+reactions+associated+with+isosulfan+blue+versus+methylene+blue+dye+in+sentinel+lymph+node+biopsy+for+breast+cancer.">A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.</a> American Journal of Surgery. 189 (2), 236-239 (2005).</li><li>Stradling, B., Aranha, G., Gabram, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Adverse+skin+lesions+after+methylene+blue+injections+for+sentinel+lymph+node+localization.">Adverse skin lesions after methylene blue injections for sentinel lymph node localization.</a> American Journal of Surgery. 184 (4), 350-352 (2002).</li></ol>

In the modern era of breast cancer surgery, SNB has replaced ALND as the standard of care for axillary staging in early breast cancer and ALND should be abandoned if the SNs are free from metastasis14,15. The lymphatic mapping technique which is commonly used in developed countries is the application of radioisotope tracer and PBD as a combined or single technique16,17. The question on how to perform SNB ...

The status of axillary lymph nodes (ALNs) metastasis is the most important prognostic factor in breast cancer. Axillary lymph node dissection (ALND) was the conventional procedure to assess metastatic status of ALNs1,2. Unfortunately, ALND results in morbidities to the patients which decreases the quality of life, especially by increasing the risk of lymphedema after this procedure3,4. Nowadays, sentinel node biopsy (SNB) has replaced ALND for axillary staging because of its minimal morbidities among patients5. The most common method for performing SNB is using radioisotope tracer and PBD6. In some parts of the world, including in developing countries, these tracer agents could be difficult to procure and searching for an alternative tracer agent is critical to solve the problem.
Initially, MBD was used by Wong et al. as a tracer agent for mapping sentinel nodes (SNs)7. In their study using a feline model, intradermal injection of MBD showed poor lymphatic uptake and isosulfan blue was chosen as the preferred dye for sentinel node (SN) mapping7. Methylene blue dye has been used in breast cancer SNB since the first successful report by Simmons et al.8. Several studies have also reported MBD as the favorable dye for SNs identification, and that the false negative rates of MBD technique were comparable to radioisotope or PBD9,10,11. Fewer allergic reactions and lower price are the other reasons to consider its use in SN mapping12.
Recently, we studied the use of 1% MBD alone for SNB in clinically node negative breast cancer. In early stages, MBD has a favorable identification rate and negative predictive value13. We inject 2 mL of 1% MBD into the subareolar space or peritumoral area if there was an excisional biopsy scar at the upper outer quadrant or nipple areolar complex (NAC) of the breast. The blue nodes and non-blue nodes with lymphatic blue channels are categorized as SNs. The anatomical landmark in the axilla is used as a guidance to find SNs. Intraoperative examination is applied to assess the metastasis and the SNs are sent for histopathology analysis based on American Society of Clinical Oncology (ASCO) Guidelines14.
If the cases are selected carefully and the skills required for this technique are obtained by the surgeons as well as pathologists, many patients could be saved from the harmful effects of ALND while still having favorable survival.

<table border="0" cellpadding="0" cellspacing="0" style="width:1046px;" width="1046">
	<tbody>
		<tr height="40">
			<td height="40" style="height:40px;width:348px;">Metiblo 50mg/5ml</td>
			<td style="width:174px;">Laboratories Sterop NV</td>
			<td style="width:353px;">BE475217</td>
			<td style="width:171px;">Methylene Blue Dye</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Disposable syringe with needle - 3mL (Luer Lock Tip)</td>
			<td>Terumo Europe NV</td>
			<td>dvr-3414</td>
			<td>Syringe for Injection</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">ForceTriad energy platform</td>
			<td>Medtronic</td>
			<td>ForceTriad</td>
			<td>Surgical cautery</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Shandon Cryomatrix embedding resin</td>
			<td>Thermo (scientific)</td>
			<td>6769006</td>
			<td rowspan="2">Frozen Section</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Cryotome FSE</td>
			<td>Thermo (scientific)</td>
			<td>77210153</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">HistoStar Embedding Workstation</td>
			<td>Thermo (scientific)</td>
			<td>A81000001</td>
			<td rowspan="3" style="width:171px;">Histopathological Examination</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Finesse Me+</td>
			<td>Thermo (scientific)</td>
			<td>A77510272</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Gemini AS</td>
			<td>Thermo (scientific)</td>
			<td>A81500002</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Benchmark GX</td>
			<td>Ventana Medical Systems</td>
			<td>750-850</td>
			<td rowspan="2">Immunohistochemistry</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Benchmark XT</td>
			<td>Ventana Medical Systems</td>
			<td>750-700</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Microscope</td>
			<td>Olympus</td>
			<td>Model BX53</td>
			<td></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;">Ultrasound</td>
			<td>Phillips</td>
			<td>HD 7XE</td>
			<td></td>
		</tr>
	</tbody>
</table>

the application of 1% methylene blue dye as a single technique in breast cancer sentinel node biopsy

In this study, we injected 1% methylene blue dye (MBD) into the subareolar or peritumoral space of the breast. In the case of breast conserving surgery (BCS), a separate incision in the lower axilla hairline was made to find the sentinel nodes (SNs). In mastectomy, the SNs were identified through the same mastectomy incision. The SNs were described as blue nodes or nodes with lymphatic blue channels. An anatomical landmark in the axilla was used to facilitate SNs identification. The SNs metastases were evaluated by intraoperative frozen section analysis and histopathology examination as it is a gold standard. Here, we described the MBD as the lone technique in breast cancer sentinel node biopsy (SNB) which could be useful when radioisotope tracer or patent or isosulfan blue dye (PBD) cannot be provided.

Here, we describe the results from the presented technique. Two milliliters of 1% MBD were injected at the deep subareolar space as the standard technique of injection (Figure 1A). If the peritumoral injection is indicated, it should be performed under ultrasound guidance (Figure 1B). The blue nodes or lymphatic blue tracts were seen after entering the axillary space. Following the lymphatic blue tracts lead to finding the SNs (<...

Watch this Scientific Journal Video about The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy at JoVE.com

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

In Indonesia, sentinel node biopsy (SNB) is not routinely performed for breast cancer surgery because of the limitation to provide radioisotope tracer and isosulfan or patent blue dye (PBD). To overcome this obstacle, we applied 1% methylene blue dye (MBD) as a single agent to map the sentinel nodes (SNs).

In this study, we injected 1% methylene blue dye (MBD) into the subareolar or peritumoral space of the breast. In the case of breast conserving surgery ...

The application of one percent methylene blue dye as a single technique in breast cancer sentinel node biopsy. The overall goal of this procedure is to show the application of blue dye alone as a single technique for early breast cancer axillary node biopsy, using 1%methylene blue dye and to show how to isosulfan examination of sentinel nodes. Section one preparation of one percent methylene blue dye and the injection technique.Section two sentinel node biopsy technique in breast conserving surgery. Section three. sentinel node biopsy technique in mastectomy.Section four pathological examination of sentinel nodes. Section five intraoperative examination. Section six results.Section seven conclusion.

Research

JoVE Journal

Cancer Research

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

The identification of functional driver events in cancer is central to furthering our understanding of cancer biology and indispensable for the discovery ...

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema

Lymphedema is one of the most common complications after breast cancer surgery. There are many diagnostic tools for lymphedema, but no standard method yet ...

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited therapeutic options. When compared to patients with less ...

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Preclinical models that faithfully recapitulate tumor heterogeneity and therapeutic response are critical for translational breast cancer research. ...

Using Computer-based Image Analysis to Improve Quantification of Lung Metastasis in the 4T1 Breast Cancer Model

Breast cancer is a devastating malignancy, accounting for 40,000 female deaths and 30% of new female cancer diagnoses in the United States in 2019 alone. ...

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Breast cancer (BC) remains a leading cause of death for women. Despite more than $700 million invested in BC research annually, 97% of candidate BC drugs ...

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Metastatic spread to the brain is a common and devastating manifestation of many types of cancer. In the United States alone, about 200,000 patients are ...

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Cancer-associated fibroblasts (CAFs) are key actors in the context of the tumor microenvironment. Despite being reduced in number as compared to tumor ...

Mammary Epithelial and Endothelial Cell Spheroids as a Potential Functional In vitro Model for Breast Cancer Research

Mammary Epithelial and Endothelial Cell Spheroids as a Potential Functional In vitro Model for Breast Cancer Research

Breast cancer is the leading cause of mortality in women. The growth of breast cancer cells and their subsequent metastasis is a key factor for its ...

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Sentinel lymph node (SLN) mapping and biopsy is a promising technique for visualizing and evaluating lymph node status in cancer. This approach has been ...